Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stryker Spine Putty Approval “Significantly” Delayed, Firm Says

This article was originally published in The Gray Sheet

Executive Summary

FDA is requesting additional data to support Stryker's OP-1 Putty PMA, which could delay approval of the posterolateral lumbar spine fusion surgery indication until 2009, the firm says

You may also be interested in...



Orthopedic Devices Panel Rejects Stryker’s OP-1 Putty For Spinal Fusion

FDA's Orthopedic and Rehabilitation Devices advisory panel voted 6-1 to recommend against approval of Stryker Biotech's OP-1 Putty spinal fusion product March 31

Orthopedic Devices Panel Rejects Stryker’s OP-1 Putty For Spinal Fusion

FDA's Orthopedic and Rehabilitation Devices advisory panel voted 6-1 to recommend against approval of Stryker Biotech's OP-1 Putty spinal fusion product March 31

Ortho Earnings: Stryker Plans Big Compliance Investment In 2009

Stryker will spend between $60 million and $90 million on compliance initiatives in 2009, as it overhauls its quality standards and resolves issues related to three outstanding FDA warning letters

Related Content

UsernamePublicRestriction

Register

MT024726

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel